2016
DOI: 10.1177/0284185115626480
|View full text |Cite
|
Sign up to set email alerts
|

Nephrogenic systemic fibrosis: a serious adverse reaction to gadolinium – 1997–2006–2016. Part 1

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
22
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
4
4

Relationship

0
8

Authors

Journals

citations
Cited by 32 publications
(22 citation statements)
references
References 39 publications
0
22
0
Order By: Relevance
“…Despite the broad medical utility of this NP system, the use of Gd-based nanomedicine has recently faced controversy related to potential toxicity issues. 516,517 …”
Section: In Vivo Treatment (“Particle-based Delivery”)mentioning
confidence: 99%
“…Despite the broad medical utility of this NP system, the use of Gd-based nanomedicine has recently faced controversy related to potential toxicity issues. 516,517 …”
Section: In Vivo Treatment (“Particle-based Delivery”)mentioning
confidence: 99%
“…Nonetheless, we believe the joints effort of various specialty societies would be a valuable way to move forward. The story of gadolinium‐related nephrogenic systemic fibrosis is a good example that marks the excellent communication between nephrologists and radiologists . Joint guidelines by responsible societies and multi‐disciplinary symposium in major conferences are potential ways to increase the awareness of AKI by other specialties.…”
Section: Epidemiology Of Aki In Hong Kongmentioning
confidence: 99%
“…NSF is a rare fibrosing disorder characterised by skin thickening on the extremities and trunk and dermal fibrosis 1 2. This disease only occurs in patients with kidney failure 2.…”
Section: Descriptionmentioning
confidence: 99%
“…This disease only occurs in patients with kidney failure 2. Development of NSF is most commonly linked to gadolinium exposure, as in gadolinium-based contrast agents (GB-CAs) 1. GB-CAs are excreted nearly exclusively by the kidney.…”
Section: Descriptionmentioning
confidence: 99%